| Tenderloin Health Services | |
|
330 Ellis St San Francisco CA 94102-2735 | |
| (415) 674-6142 | |
| (415) 885-8512 |
| Full Name | Tenderloin Health Services |
|---|---|
| Speciality | Clinic/Center |
| Location | 330 Ellis St, San Francisco, California |
| Authorized Official Name and Position | Vitka Eisen (CEO) |
| Authorized Official Contact | 4157623700 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Tenderloin Health Services 1563 Mission St, 4th Floor San Francisco CA 94103-2543 Ph: (415) 762-3700 | Tenderloin Health Services 330 Ellis St San Francisco CA 94102-2735 Ph: (415) 674-6142 |
| NPI Number | 1447279310 |
|---|---|
| Provider Enumeration Date | 07/19/2006 |
| Last Update Date | 08/21/2017 |
| Medicare PECOS PAC ID | 3678674025 |
|---|---|
| Medicare Enrollment ID | O20150810001655 |
News Archive
Even with the best available treatments, the median survival of patients with metastatic, hormone-refractory prostate cancer is only two to three years. Driven by the need for more effective therapies for these patients, researchers at VCU Massey Cancer Center and the VCU Institute of Molecular Medicine have developed a unique approach that uses microscopic gas bubbles to deliver directly to the cancer a viral gene therapy in combination with an experimental drug that targets a specific gene driving the cancer's growth.
Currently, one in five elderly patients discharged from a hospital is readmitted within a month. Seeking to address the human and substantial financial burden of revolving door hospital readmissions, the Affordable Care Act proposes a number of initiatives to improve care and health outcomes and reduce costs for the growing population of chronically ill people in the U.S. While transitional care is a central theme in these provisions, there is little information available to guide those responsible for implementing these important opportunities.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).
About 15 million Americans will have either Alzheimer's dementia or mild cognitive impairment by 2060, up from approximately 6.08 million this year, according to a new study by researchers at the UCLA Fielding School of Public Health.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447279310 | NPI | - | NPPES |
| 091070 | Other | CA | FQHC UDS |
| 220000473 | Other | CA | COMMUNITY CLINIC LICENSE |
News Archive
Even with the best available treatments, the median survival of patients with metastatic, hormone-refractory prostate cancer is only two to three years. Driven by the need for more effective therapies for these patients, researchers at VCU Massey Cancer Center and the VCU Institute of Molecular Medicine have developed a unique approach that uses microscopic gas bubbles to deliver directly to the cancer a viral gene therapy in combination with an experimental drug that targets a specific gene driving the cancer's growth.
Currently, one in five elderly patients discharged from a hospital is readmitted within a month. Seeking to address the human and substantial financial burden of revolving door hospital readmissions, the Affordable Care Act proposes a number of initiatives to improve care and health outcomes and reduce costs for the growing population of chronically ill people in the U.S. While transitional care is a central theme in these provisions, there is little information available to guide those responsible for implementing these important opportunities.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).
About 15 million Americans will have either Alzheimer's dementia or mild cognitive impairment by 2060, up from approximately 6.08 million this year, according to a new study by researchers at the UCLA Fielding School of Public Health.
› Verified 4 days ago
Richard Joseph Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 548 Market St # 50727, San Francisco, CA 94104 Phone: 415-851-3224 | |
James Y.greenberg, Md, A Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2299 Post St Ste 205, San Francisco, CA 94115 Phone: 415-474-7955 Fax: 415-292-0718 | |
Inpatient Services Of California, Inc., A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3555 Cesar Chavez St, San Francisco, CA 94110 Phone: 415-641-6401 | |
Jew & Jew Medical Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 919 Clay St, San Francisco, CA 94108 Phone: 415-982-4011 Fax: 415-982-6291 | |
Hampton Health Ltd Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1700 California St, Ste. 470, San Francisco, CA 94109 Phone: 415-202-9990 Fax: 415-843-0548 | |
North East Medical Services-leland Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 82 Leland Avenue, San Francisco, CA 94134 Phone: 415-391-9686 Fax: 415-333-9067 | |
Mission Area Health Associates Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1580 Valencia St Ste 506, San Francisco, CA 94110 Phone: 415-852-4080 Fax: 415-431-3178 |